Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders
- Conditions
- Placenta Accreta Spectrum
- Interventions
- Other: Conservative/Expectant Management
- Registration Number
- NCT06512181
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
This study for the conservative management of placenta accreta spectrum disorders (PAS), which are a major cause of maternal morbidity and mortality. The most common management strategy for PAS in the United States is a preterm cesarean-hysterectomy. However, accumulating data show that conservative management is safer and is preferred by some patients. In selected participants (n=15) who desire uterine preservation, the investigators provide the option of conservative management, which will be defined as leaving the placenta in the uterus after delivery of the infant. This is a single-arm single-site pilot study where all participants will be carefully monitored during a standard postpartum inpatient stay and with outpatient follow-up until the uterus is empty.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 15
- Provision of signed and dated informed consent form.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- A person with a uterus, age 18 or older
- Currently 16-36 weeks pregnant with an intrauterine gestation
- History of cesarean delivery AND placenta previa OR anterior low-lying placenta AND suspected of having PAS on prenatal imaging (ultrasound/MRI)
- Patients for whom the usual management would be cesarean-hysterectomy.
- Patient desires uterine preservation
- Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration.
• Have a low antenatal suspicion for PAS based on imaging.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Uterine preservation Conservative/Expectant Management Conservative management of PAS with the inclusion of antibiotics and uterine artery embolization, followed by close monitoring.
- Primary Outcome Measures
Name Time Method Hysterectomy rate Delivery through 1 year Percent of participants who undergo a hysterectomy
- Secondary Outcome Measures
Name Time Method Endometritis rate Delivery through 1 year Percent of participants who have endometritis
Frequency of vaginal bleeding Delivery through 1 year Percent of participants with vaginal bleeding at each time point
Frequency of pelvic pain Delivery through 1 year Percent of participants with pelvic pain at each time point
Coagulopathy rate Delivery through 1 year Percent of participants who have coagulopathy
Trial Locations
- Locations (1)
Hospital of the University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States